Skip to main content
Clinical Trials/NCT06684613
NCT06684613
Recruiting
N/A

Project Carmenta: Integrating PrEP Decision Making Into Counseling in Sexual and Reproductive Health Clinics

Yale University1 site in 1 country50 target enrollmentFebruary 1, 2026

Overview

Phase
N/A
Intervention
PrEP Decision Aid
Conditions
Sexual Risk Behavior for HIV-infection
Sponsor
Yale University
Enrollment
50
Locations
1
Primary Endpoint
PrEP initiation (prescribing)
Status
Recruiting
Last Updated
2 months ago

Overview

Brief Summary

This study addresses the need for HIV prevention to be integrated into counseling visits at sexual and reproductive health clinics.

Detailed Description

The purpose of this study is to expand and enhance a PrEP decision aid to include the full array of available formulation options and then integrate its delivery into sexual and reproductive health settings during counseling visits, where PrEP can be provided to all women who are interested. Rooted in health implementation frameworks, this study evaluates health and implementation determinants simultaneously along: 1) innovation characteristics; 2) clinical encounter; 3) recipients; and 4) context. In Aim 1, patients (n=15-20), clinicians (n=10), and staff (n=10) at sexual and reproductive health clinics across Greater New Haven, CT will be engaged for semi-structured interviews to expand and enhance an existing PrEP decision aid to include all available formulations and optimize its integration into sexual and reproductive health clinics. Qualitative interviews will inform infrastructure development to support PrEP delivery in sexual and reproductive health clinics. In Aim 2 (a hybrid Type 2 effectiveness-implementation study), patients will be randomized (n=50) to receive either the PrEP decision aid or generic PrEP information prior to a clinician visit. In follow-up interviews immediately post-visit, and at Months 3 and 6, primary outcomes are clinical efficacy (PrEP initiation) and implementation (using Proctor definitions for feasibility, acceptability, penetration, and adoption) that are important for future planned scale-up.

Registry
clinicaltrials.gov
Start Date
February 1, 2026
End Date
September 5, 2027
Last Updated
2 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients (inclusion):
  • Aged 18 years or older
  • Have a uterus
  • Do not have HIV (by self-report)
  • Not currently on PrEP
  • Comfortable conversing in English or Spanish
  • Able to participate in informed consent procedures
  • Patients (exclusion):
  • People who cannot become pregnant (i.e., have had a hysterectomy or tubal ligation)
  • People who wish to become pregnant (will not qualify for pregnancy prevention counseling)

Exclusion Criteria

  • Not provided

Arms & Interventions

PrEP Decision Aid

Participants randomized to the decision aid (active intervention arm), will interact with the enhanced PrEP decision aid in REDCap. This is an individualized, patient-facing decision aid that supports informed patient choice and is interactive. In contrast to shared decision aids that guide a clinical encounter, the participants uses the individualized decision aid prior to the clinical encounter to discretely assess HIV risk and build awareness before discussing with their clinician

Intervention: PrEP Decision Aid

Generic Information

Participants randomized to this arm will be asked to watch a CDC-produced video, "PrEP (Pre-Exposure Prophylaxis)" (available online free of charge through CDC website) that will serve as a time- and attention-based control.

Intervention: Generic Information

Outcomes

Primary Outcomes

PrEP initiation (prescribing)

Time Frame: 6 months

Whether PrEP was prescribed (yes/no) in the EHR within the 6-month time frame

Feasibility of implementing the enhanced PrEP decision aid in SRH settings, according to the Proctor taxonomy

Time Frame: 6 months

Feasibility is defined as the extent to which the enhanced PrEP decision aid can be successfully used in SRH clinic settings (qualitative).

Acceptability of the enhanced PrEP decision aid within SRH settings, according to users (Proctor taxonomy)

Time Frame: 6 months

Acceptability is defined as the user perception that the enhanced PrEP decision aid is acceptable in SRH settings.

Adoption of the enhanced PrEP decision aid within SRH settings, according to users (Proctor taxonomy)

Time Frame: 6 months

Adoption of the enhanced decision aid into SRH clinics, assessed by whether PrEP was discussed during the visit (yes/no)

Penetration (reach) of the enhanced decision aid within SRH clinics (Proctor taxonomy)

Time Frame: 6 months

Penetration (reach) of the intervention, measured by recruitment rate (number of participants enrolled per month)

Secondary Outcomes

  • PrEP initiation (dispensing)(6 months)
  • PrEP initiation (first use)(6 months)
  • PrEP persistence(6 months)
  • PrEP adherence(6 months)

Study Sites (1)

Loading locations...

Similar Trials